A donor happily giving blood during the recent blood at JCB high school in Phoenix. PHOENIX, NY – John C. Birdlebough High School in Phoenix recently hosted its first blood drive of the school year. Thanks to an abundance of donors, the school surpassed its collection goal for the day. Members of the school’s National […]
Enlarge / Wegovy an injectable prescription weight loss medicine that has helped people with obesity. Getty | Michael Siluk The blockbuster diabetes and weight loss drug semaglutide (Wegovy, Ozempic, Rybelsus) reduced the relative risk of heart attack, stroke, or cardiovascular deaths by 20 percent in high-risk patients with cardiovascular disease but not diabetes during a […]
What You Should Know: STAT Health emerges from stealth to introduce a 24/7 in-ear wearable that measures blood flow to the head to better understand symptoms such as dizziness, brain fog, headaches, fainting, and fatigue that occur upon standing. These are common symptoms for illnesses like long COVID, postural orthostatic tachycardia syndrome (POTS), myalgic encephalomyelitis / […]
A Phase II trial for the small interfering RNA (siRNA) therapeutic lepodisiran is currently underway, assessing its ability to reduce lipoprotein(a) levels. A single dose of lepodisiran, a small interfering RNA (siRNA) therapeutic, produced over 94 percent reductions in blood levels of lipoprotein(a), also known as Lp(a), with the results lasting for nearly a year, […]
A 12 lead ECG showing atrial fibrillation at approximately 150 beats per minute. Credit: James Heilman, MD/Wikipedia/CC BY-SA 3.0 The widely available blood thinner apixaban substantially reduced stroke in at-risk patients with a type of atrial fibrillation only detectable by a pacemaker or other implanted cardiac electronic device, a global study has found. The oral […]
The VP&S Office of Faculty Affairs has provided this list of full-time faculty who joined the medical school in August 2023. Amit Batta, DO, Psychiatry Jehanne Belange, MD, Emergency Medicine Tom D. Ben Dov, MD, Otolaryngology/Head & Neck Surgery: Ben Dov has joined the Division of Pediatric Otolaryngology. His research interests focus on the genomics […]
Novo Nordisk has made a splash with its GLP-1 drugs that have allowed patients to achieve significant weight loss. Now the Danish company appears on the verge of another breakthrough, showing that the use of its obesity treatment Wegovy can reduce the risk of heart attack in some patients. Perhaps even more importantly, Novo said […]
The Food and Drug Administration (FDA) has approved Adzynma for prophylactic or on-demand enzyme replacement therapy (ERT) in adult and pediatric patients with congenital thrombotic thrombocytopenic purpura. Congenital thrombotic thrombocytopenic purpura (cTTP) results from a deficiency in ADAMTS13 (A disintegrin and metalloproteinase with thrombospondin motifs 13), a von Willebrand factor (VWF) cleaving protease. This leads […]
(CNN) – Results from a landmark clinical trial this summer suggested, for the first time, that a medication given for weight loss alone could reduce the risk of heart attack, stroke or heart-related death in people with cardiovascular disease, bolstering physicians’ excitement about an already-exploding class of new medicines. Novo Nordisk’s Wegovy, part of the […]
Data presented at a meeting of the American Heart Association on Saturday indicates cardiovascular protective benefits from taking the weight loss therapeutic Wegovy for a sub-population with preexisting cardiovascular disease. But the absolute risk reduction is quite small. Payers will take notice of this in addition to the timing aspect with respect to when the […]